IDiyas

For the Inventor, By the Inventor

West Lafayette, IN, United States of America

Melanie Janelle Bevill

USPTO Granted Patents = 20 

 

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 38(Granted Patents)


Location History:

  • Lafayette, IN (US) (2017)
  • West Lafayette, IN (US) (2013 - 2024)

Company Filing History:

goldMedal6 out of 7 
 
Amri Ssci, LLC
 patents
silverMedal5 out of 63 
 
Salix Pharmaceuticals, Inc.
 patents
bronzeMedal3 out of 14 
 
Aeromics, Inc.
 patents
4. 2 out of 61 
 
Reata Pharmaceuticals, Inc.
 patents
5. 1 out of 173 
 
Exelixis, Inc.
 patents
6. 1 out of 39 
 
Ambit Biosciences Corporation
 patents
7. 1 out of 64 
 
Alfa Wassermann S.p.a.
 patents
8. 1 out of 574 
 
Ono Pharmaceutical Co., Ltd.
 patents
9. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...
Loading Chart...
20 patents (USPTO):
1. 12459890 - Salt and crystal form of compound having agonistic activity to S1P5 receptor (2025-11-04),
2. 12091431 - Crystals (2024-09-17),
3. 12017995 - Crystalline forms and salt forms of a kinase inhibitor (2024-06-25),
4. 11725018 - Crystals (2023-08-15),
5. 11401294 - Co-crystal forms of a novobiocin analog and proline (2022-08-02),
6. 11117909 - Crystals (2021-09-14),
7. 10717755 - Co-crystal forms of a novobiocin analog and proline (2020-07-21),
8. 10098859 - Cocrystals of p-coumaric acid (2018-10-16),
9. 10004726 - Polymorphs of cocrystals of P-coumaric acid:nicotinamide (2018-06-26),
10. 9982007 - Cocrystals of progesterone (2018-05-29),
11. 9700545 - Forms of rifaximin and uses thereof (2017-07-11),
12. 9585892 - Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith (2017-03-07),
13. 9512166 - Cocrystals of progesterone (2016-12-06),
14. 9359357 - Forms of rifaximin and uses thereof (2016-06-07),
15. 9314459 - Polymorphs of cocrystals of p-Coumaric acid:nicotinamide (2016-04-19),

Title: **Melanie Janelle Bevill: A Pioneer in Pharmaceutical Innovations**

Introduction

Melanie Janelle Bevill is a prominent inventor based in West Lafayette, Indiana. With a remarkable portfolio of 19 patents, she has made significant contributions to the field of pharmaceuticals, particularly in developing innovative compounds and methodologies.

Latest Patents

Among her latest patents is a groundbreaking invention related to crystals, specifically for 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate. This patent includes not only the crystallization method but also the compositions and applications of these crystals. Another notable invention pertains to crystalline forms and salt forms of a kinase inhibitor, which are crucial for treating diseases associated with protein kinases. This invention outlines the pharmaceutical compositions and methods for using these solid polymorphs effectively.

Career Highlights

Throughout her impressive career, Melanie has held key positions in renowned companies such as AMRI SSCI, LLC and Salix Pharmaceuticals, Inc. Her work in these organizations has led to the development of novel pharmaceutical solutions that address various medical challenges.

Collaborations

Melanie has had the opportunity to collaborate with talented professionals in her field, including her notable coworkers Stephan D Parent and Nathan Carl Schultheiss. These collaborations have further enriched her innovative endeavors, contributing to the success of her patents.

Conclusion

Melanie Janelle Bevill's dedication to her work in pharmaceutical innovations is evident through her extensive patent portfolio. As she continues to explore new frontiers in medicine, her contributions will undoubtedly leave a lasting impact on the industry and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…